| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,255 |
20,367 |
$1.30M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,348 |
10,494 |
$976K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,729 |
5,667 |
$440K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,794 |
5,266 |
$415K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,566 |
3,538 |
$271K |
| 92552 |
|
8,341 |
8,255 |
$220K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,069 |
2,047 |
$169K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,762 |
3,648 |
$100K |
| 90670 |
|
3,289 |
3,216 |
$97K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,158 |
3,073 |
$94K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,025 |
4,880 |
$66K |
| 90698 |
|
3,019 |
2,936 |
$57K |
| 90671 |
|
924 |
903 |
$52K |
| 90651 |
|
998 |
990 |
$45K |
| 90680 |
|
2,500 |
2,425 |
$44K |
| 90686 |
|
2,674 |
2,602 |
$30K |
| 90633 |
|
1,880 |
1,856 |
$25K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,115 |
12,742 |
$22K |
| 90744 |
|
1,600 |
1,528 |
$19K |
| 94760 |
|
9,799 |
8,889 |
$17K |
| 96127 |
|
3,539 |
3,479 |
$17K |
| 87807 |
|
1,230 |
1,180 |
$16K |
| 99173 |
|
6,478 |
6,423 |
$15K |
| 87081 |
|
1,715 |
1,661 |
$12K |
| 99000 |
|
3,495 |
3,357 |
$12K |
| 90619 |
|
270 |
269 |
$11K |
| 90688 |
|
853 |
837 |
$10K |
| 90734 |
|
311 |
310 |
$10K |
| 90710 |
|
216 |
211 |
$9K |
| 99381 |
|
123 |
113 |
$9K |
| 99215 |
Prolong outpt/office vis |
69 |
62 |
$9K |
| 99177 |
|
1,955 |
1,931 |
$8K |
| 92551 |
|
788 |
782 |
$8K |
| 90461 |
|
5,813 |
5,649 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
841 |
827 |
$7K |
| 90656 |
|
460 |
459 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
176 |
172 |
$6K |
| 90687 |
|
416 |
410 |
$5K |
| 90677 |
|
135 |
129 |
$5K |
| 96160 |
|
1,727 |
1,637 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
313 |
280 |
$4K |
| 99383 |
|
46 |
44 |
$4K |
| 0072A |
|
94 |
94 |
$4K |
| 90696 |
|
194 |
191 |
$3K |
| 90715 |
|
216 |
215 |
$3K |
| 90620 |
|
59 |
59 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
161 |
155 |
$3K |
| 0071A |
|
77 |
70 |
$3K |
| 90716 |
|
99 |
99 |
$3K |
| 0001A |
|
64 |
63 |
$3K |
| 90700 |
|
202 |
200 |
$2K |
| 87428 |
|
15 |
15 |
$2K |
| 90707 |
|
102 |
102 |
$2K |
| 99188 |
|
71 |
71 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,374 |
1,306 |
$1K |
| 0002A |
|
32 |
32 |
$1K |
| 90648 |
|
110 |
109 |
$1K |
| 90381 |
|
22 |
21 |
$1K |
| 90380 |
|
13 |
12 |
$1K |
| 90685 |
|
96 |
91 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$986.18 |
| 0124A |
|
32 |
24 |
$960.00 |
| 94664 |
|
45 |
44 |
$668.91 |
| 96380 |
|
33 |
32 |
$579.60 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
43 |
34 |
$386.54 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
23 |
23 |
$287.50 |
| A7015 |
Aerosol mask, used with dme nebulizer |
135 |
121 |
$155.31 |
| 96161 |
|
65 |
52 |
$154.88 |
| 99051 |
|
99 |
95 |
$85.00 |
| 99072 |
|
3,466 |
3,265 |
$60.00 |
| 87400 |
|
13 |
13 |
$27.72 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
14 |
14 |
$23.80 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
309 |
278 |
$8.76 |
| A4616 |
Tubing (oxygen), per foot |
160 |
144 |
$8.15 |
| 91307 |
|
348 |
336 |
$2.97 |
| 91300 |
|
211 |
203 |
$1.74 |
| 91312 |
|
32 |
24 |
$0.23 |
| 91308 |
|
18 |
16 |
$0.10 |
| 3078F |
|
2,095 |
2,010 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
31 |
31 |
$0.00 |
| 3074F |
|
2,175 |
2,084 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,629 |
1,618 |
$0.00 |
| 90480 |
|
34 |
34 |
$0.00 |
| 3079F |
|
38 |
38 |
$0.00 |